Nuvation Bio

On #InternationalWomensDay, we are proud to recognize our female colleagues and their contributions. To all the trailblazers at Nuvation Bio, we appreciate you! #IWD2025 

Today is #EmployeeAppreciationDay, and we are thrilled to celebrate the Nuvation Bio team worldwide! With your patient focus, dedication and expertise, we have transformed our organization and potential impact. Scroll through the slideshow for some of our team and gratitude from our Chief People Officer, Stacy Markel. 

Today we reported fourth quarter and full year 2024 financial results and provided a business update. Learn more: https://lnkd.in/eZ9tt_pa   #oncology #cancer #biotech 

We are pleased to announce that we have secured up to $250 million in non-dilutive financings from Sagard Healthcare Partners. This transaction allows us to fund our upcoming potential U.S. commercial launch in advanced #ROS1 positive #NSCLC, develop our clinical-stage #oncology pipeline, and create a path to profitability. Read the news: https://lnkd.in/eQMuQ23t

We look forward to our presentation at the TD Cowen 45th Annual Health Care Conference. Join us to hear David Hung, M.D., our Founder, President, and CEO, discuss Nuvation Bio’s recent progress: https://lnkd.in/eQ3a9bfZ   #biotech #cancer #oncology 

Today we are excited to celebrate International Day of Women and Girls in Science! Please join us in reading the important perspectives of Veronica Nagy, Spandana Vootukuri and Jill Daigneault Ph.D. and honoring all of our female colleagues. We appreciate all you do! #IDWGS #WomeninScience #February11

On #WorldCancerDay, we honor patients, loved ones and caregivers affected by #cancer, who motivate us to urgently tackle their greatest unmet needs. Reflecting on today’s theme, #UnitedbyUnique, we appreciate that everyone’s experience is different, and that people are more than their disease. We are committed to this patient-centric spirit as we develop new therapies for the most difficult-to-treat #cancers. Learn more: https://lnkd.in/emtD8T6s

We are pleased to open an Expanded Access Program (EAP) for our lead product candidate in advanced #ROS1 positive #NSCLC and provide eligible patients in the U.S. with access to this treatment option. Read more: https://lnkd.in/eUhx4WAm

As a key Nuvation Bio Market Access team member, Shane J., PharmD, Senior Director, Clinical Value and Outcomes, is motivated to redefine excellence so that patients with #cancer receive the medications they need. To achieve this vision, Shane and the team collaborate closely to share the clinical value story with stakeholders and build trusted partnerships. We appreciate the full Nuvation team for their dedication to patients day in and day out! #NSCLC #oncology #biotech 

We look forward to our presentation next Monday at the 43rd Annual J.P. Morgan Healthcare Conference. David Hung, M.D., our Founder, President, and CEO, will discuss Nuvation’s recent progress and significant year ahead. Watch here: https://bit.ly/3Vazma1   #JPM2025 #cancer #oncology